This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
1 Apr 2019

Sartorius integrates online biomass measurement to its ambr systems for microbial applications

Scientists to rapidly obtain detailed process understanding and control over their microbial cultures.

Sartorius Stedim Biotech (SSB) is introducing integrated online biomass measurement to its ambr 15 fermentation and ambr 250 high throughput systems for microbial applications.

Already well known in the industry for fast-tracking microbial screening studies and shortening process development timelines, the ambr 15 fermentation and ambr 250 high throughput systems operate up to 24 single-use stirred bioreactor cultures in parallel. With the integration of online biomass measurement, SSB has addressed the bottleneck associated with offline sampling. The new online biomass capability features state-of-the-art non-invasive reflectance measurement, saving time, effort and sample volume. It enables scientists to rapidly obtain detailed process understanding and control over their microbial cultures.

Online biomass measurement provides real-time non-invasive, continuous growth monitoring of 24 microbial cultures running in parallel. The reflectance-based technology means that sampling is not required. Instead, it uses lasers to transmit light through the base of each bioreactor and microprocessors to translate this into a reflectance measurement. With a wide dynamic measurement range, and bubble correction factors to take into account gas bubble density, reliable online measurements can be achieved even in high aeration and agitation environments. Through a user calibration process, online reflectance can be displayed as online optical density (OD), wet cell weight (WCW) or dry cell weight (DCW). To date, the online biomass measurement has been successfully tested with different organisms including E.coli, Pichia pastoris, Saccharomyces cerevisiae, Streptomyces spp. and Corynebacterium spp.

“Fermentation scientists often have to perform time-consuming sampling to monitor growth and initiate process control based on offline data. Sample preparation and manual data handling can introduce variability and errors; it may also necessitate samples being taken at unsociable hours or over weekends,” explained Alison Rees-Manley, ambr 15 Product Manager at SSB. “By integrating innovative biomass monitoring technology into our ambr systems for microbial applications, we enable real-time growth data to be used for more advanced process control. We’re confident that these ambr systems will help scientists by reducing the burden of offline sampling and providing better process understanding and greater control of microbial cultures. This will result in more accurate and predictive data for cost-efficient protein production,” she added.

Mentioned Companies
Sartorius Stedim Biotech GmbH
View company profile

Related News

  • News Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel

    A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...
  • News Protecting life-saving therapies: CPHI Online Podcast Series

    The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.

  • News 2026 Outsourcing Outlook Update - pharma at a crossroads

    The pharmaceutical contract development and manufacturing organisation (CDMO) sector is experiencing unprecedented transformation, driven by evolving therapeutic complexities, geopolitical tensions, and the growing demand for specialised manufacturing ...
  • News Roche maintains German investment commitment whilst rivals scale back

    Pharmaceutical giant Roche has reaffirmed its commitment to investing in Germany, standing firm even as competitors Eli Lilly and Boehringer Ingelheim dramatically reduce their planned investments in response to controversial healthcare reforms.

  • News Women in Pharma: The History of CPHI Women in Japan

    Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.
  • News EU drafts deal to end essential medicines shortage

    European negotiators have agreed new legislation to tackle persistent shortages of essential medicines by prioritising supply security over price in public procurement and supporting domestic pharmaceutical manufacturing with strategic funding.

  • News Thermo Fisher Scientific offloads microbiology business to PE firm Astorg

    The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th...
  • News The Shift: Why Sustainability is Moving to the Centre of CPHI Milan 2026

    CPHI Online contributor David Roach takes a look at how conversations around sustainability in the pharmaceutical industry can and must be transformed into actionable deliveries, and what the inaugural CPHI Sustainability Summit means for the industry.